A Novel Arene Trifluoromethyl-Based 18 F-Labeling Strategy for Enhanced Biomolecular Tracer Development in PET Imaging
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c00333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Xinlin Zhong und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, P. R. China. Hauptthemen laut MEDLINE: Fluorine Radioisotopes, Positron-Emission Tomography, Radiopharmaceuticals. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Jiangsu Commission of Health.
Abstract (Originalsprache)
Biologically active molecules, such as carbohydrates, peptides, and proteins, are attractive candidates for positron emission tomography (PET) imaging because of their strong target affinity and biocompatibility. Among available radionuclides, fluorine-18 ( 18 F) is widely used in clinical practice because of its moderate half-life and high-quality imaging properties. However, traditional 18 F-labeling methods often require a laborious procedure and harsh conditions, which may compromise the structural integrity and biological functions. Developing mild and efficient 18 F-labeling strategies is therefore critical for advancing biomolecular PET tracers. In this study, we developed a novel clickable 18 F-labeled synthon, 1-ethynyl-3-([ 18 F]trifluoromethyl)-5-(trifluoromethyl)benzene ([ 18 F] 1 ), prepared via an 18 F/ 19 F isotope exchange reaction (RCY = 17.2 ± 3.9%). [ 18 F] 1 exhibited excellent performance in copper(I)-catalyzed azide–alkyne cycloaddition (CuAAC) conjugation, enabling rapid and chemoselective labeling of azide-modified glucose derivatives, Arg-Gly-Asp (RGD) and cyclic RGD (cRGD) peptides, and phospholipids under mild conditions. PET imaging in U87 MG, 4T1, and BT474 xenograft models showed favorable tumor uptake for both [ 18 F] 5a and [ 18 F] 5b, peaking at 30 min postinjection. Tumor accumulation for [ 18 F] 5a reached 3.11 ± 0.21, 2.40 ± 0.17, and 1.95 ± 0.09% ID/g in U87 MG, 4T1, and BT474 models, respectively, while [ 18 F] 5b achieved higher values of 5.19 ± 0.42, 4.90 ± 0.97, and 2.05 ± 0.11% ID/g at the same time point─consistent with the superior binding affinity of cRGD. Tumor-to-muscle ratios were favorable, with[ 18 F] 5b reaching 4.32 ± 0.39 in the 4T1 model. Blocking studies in U87 tumors confirmed high binding specificity, with uptake reduced to approximately 1% ID/g. This isotope exchange-based CuAAC labeling strategy streamlines PET tracer synthesis, preserves biomolecule integrity, and offers a versatile platform for molecular imaging and pretargeting applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, P. R. China.
- NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, P. R. China.
- School of Chemical and Material Engineering, Jiangnan University, Wuxi 214122, P. R. China.
- Affiliated Women's Hospital of Jiangnan University, Jiangnan University, Wuxi 214002, P. R. China.
ORCID-Profile: Junjie Yan, Xinyu Wang, Min Yang
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Jiangsu Commission of Health
- Jiangsu Provincial Medical Key Laboratory (Key Laboratory of Nuclear Medicine)
Zitieren
APA
Zhong, X., Yan, J., Su, C., Wang, X., Pan, D., Xu, Y., Wang, L., Chen, C., & Yang, M. (2025). A Novel Arene Trifluoromethyl-Based 18 F-Labeling Strategy for Enhanced Biomolecular Tracer Development in PET Imaging. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00333
Vancouver
Zhong X, Yan J, Su C, Wang X, Pan D, Xu Y, et al. A Novel Arene Trifluoromethyl-Based 18 F-Labeling Strategy for Enhanced Biomolecular Tracer Development in PET Imaging. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00333
BibTeX
@article{Zhong2025,
author = {Zhong, Xinlin and Yan, Junjie and Su, Chen and Wang, Xinyu and Pan, Donghui and Xu, Yuping and Wang, Lizhen and Chen, Chongyang and Yang, Min},
title = {A Novel Arene Trifluoromethyl-Based 18 F-Labeling Strategy for Enhanced Biomolecular Tracer Development in PET Imaging},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c00333}
}
EUVIMED